Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.
Clappier E, Auclerc MF, Rapion J, Bakkus M, Caye A, Khemiri A, Giroux C, Hernandez L, Kabongo E, Savola S, Leblanc T, Yakouben K, Plat G, Costa V, Ferster A, Girard S, Fenneteau O, Cayuela JM, Sigaux F, Dastugue N, Suciu S, Benoit Y, Bertrand Y, Soulier J, Cavé H. Clappier E, et al. Leukemia. 2014 Jan;28(1):70-7. doi: 10.1038/leu.2013.277. Epub 2013 Sep 25. Leukemia. 2014. PMID: 24064621
Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively.
Dal Bello R, Pacchiardi K, Chauvel C, Adès L, Braun T, Pasanisi J, Fournier E, Berthon C, Clappier E, Raffoux E, Lebon D, Cluzeau T, Roumier C, Plesa A, Celli-Lebras K, Dombret H, Preudhomme C, Mathis S, Puissant A, Gardin C, Itzykson R. Dal Bello R, et al. Among authors: clappier e. Hemasphere. 2022 Dec 19;7(1):e819. doi: 10.1097/HS9.0000000000000819. eCollection 2023 Jan. Hemasphere. 2022. PMID: 36570694 Free PMC article. No abstract available.
Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M.
Fandrei D, Huynh T, Sébert M, Aguinaga L, Bisio V, Kim R, Clappier E, Espéli M, Balabanian K, Moins-Teisserenc H, Toubert A, Dulphy N, Fenaux P, Adès L, Zhao LP. Fandrei D, et al. Among authors: clappier e. Blood Cancer J. 2023 Dec 21;13(1):193. doi: 10.1038/s41408-023-00965-w. Blood Cancer J. 2023. PMID: 38123548 Free PMC article. No abstract available.
Uncovering new layers of Ph+ ALL biology.
Kim R, Clappier E. Kim R, et al. Among authors: clappier e. Blood. 2024 Apr 4;143(14):1322-1323. doi: 10.1182/blood.2023023583. Blood. 2024. PMID: 38573608 No abstract available.
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.
Boy M, Bisio V, Zhao LP, Guidez F, Schell B, Lereclus E, Henry G, Villemonteix J, Rodrigues-Lima F, Gagne K, Retiere C, Larcher L, Kim R, Clappier E, Sebert M, Mekinian A, Fain O, Caignard A, Espeli M, Balabanian K, Toubert A, Fenaux P, Ades L, Dulphy N. Boy M, et al. Among authors: clappier e. Nat Commun. 2023 Feb 3;14(1):588. doi: 10.1038/s41467-023-36193-w. Nat Commun. 2023. PMID: 36737440 Free PMC article.
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique.
Cauwelier B, Cavé H, Gervais C, Lessard M, Barin C, Perot C, Van den Akker J, Mugneret F, Charrin C, Pagès MP, Grégoire MJ, Jonveaux P, Lafage-Pochitaloff M, Mozzicconacci MJ, Terré C, Luquet I, Cornillet-Lefebvre P, Laurence B, Plessis G, Lefebvre C, Leroux D, Antoine-Poirel H, Graux C, Mauvieux L, Heimann P, Chalas C, Clappier E, Verhasselt B, Benoit Y, Moerloose BD, Poppe B, Van Roy N, Keersmaecker KD, Cools J, Sigaux F, Soulier J, Hagemeijer A, Paepe AD, Dastugue N, Berger R, Speleman F. Cauwelier B, et al. Among authors: clappier e. Leukemia. 2007 Jan;21(1):121-8. doi: 10.1038/sj.leu.2404410. Epub 2006 Oct 12. Leukemia. 2007. PMID: 17039236
100 results